In Vivo Dosimetry for Brachytherapy Study
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorEast and North Hertfordshire NHS Trust
About this trial
The main study aim is the investigate the clinical use of in vivo dosimeters (small measurement devices) for brachytherapy (internal radiotherapy).
Eligibility criteria
Qualifiers
Patients aged 18 years and above
histologically/radiologically proven primary or locally recurrent prostate cancer
locally advanced gynaecological malignancy in the primary and recurrent setting
primary cervix carcinoma (squamous, adenocarcinoma, adenosquamous) FIGO IB2-IVA
Disqualifiers
Previous brachytherapy exposure to the treatment site
Patients unable to give informed consent
Patients unable to have a regional or general anaesthetic
Patients with the following medical conditions: coagulopathies, history of another primary malignancy, known allergy or sensitivity to study materials; previous or current fistulae
Trial design
Treatments tested in this trial
- Not listed
Trial groups
20 Participants
are grouped into 2 trial groupsSponsors and collaborators
East and North Hertfordshire NHS Trust
Lead sponsor
TRUEinvivo Limited
Collaborator
Source ClinicalTrials.gov